Zynex/$ZYXI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Zynex
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Ticker
$ZYXI
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
1,000
ISIN
US98986M1036
Website
Zynex Metrics
BasicAdvanced
$69M
-
-$0.24
1.10
-
Price and volume
Market cap
$69M
Beta
1.1
52-week high
$10.63
52-week low
$1.66
Average daily volume
203K
Financial strength
Current ratio
3.457
Quick ratio
2.323
Long term debt to equity
330.548
Total debt to equity
351.593
Interest coverage (TTM)
-2.97%
Management effectiveness
Return on assets (TTM)
-4.11%
Return on equity (TTM)
-27.52%
Valuation
Price to revenue (TTM)
0.418
Price to book
3.3
Price to tangible book (TTM)
-10.32
Price to free cash flow (TTM)
-162.724
Growth
Revenue change (TTM)
-8.63%
Earnings per share change (TTM)
-200.34%
3-year revenue growth (CAGR)
7.90%
3-year earnings per share growth (CAGR)
-20.97%
What the Analysts think about Zynex
Analyst ratings (Buy, Hold, Sell) for Zynex stock.
Zynex Financial Performance
Revenues and expenses
Zynex Earnings Performance
Company profitability
Zynex News
AllArticlesVideos
Lost Money on Zynex, Inc. (ZYXI)? Contact Levi & Korsinsky Before May 19, 2025 to Join Class Action
Accesswire·3 days ago
Zynex, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; May 19, 2025 Deadline to file Lead Plaintiff Motion
GlobeNewsWire·3 days ago
ZYXI Investors Have Opportunity to Lead Zynex, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Business Wire·4 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Zynex stock?
Zynex (ZYXI) has a market cap of $69M as of May 23, 2025.
What is the P/E ratio for Zynex stock?
The price to earnings (P/E) ratio for Zynex (ZYXI) stock is 0 as of May 23, 2025.
Does Zynex stock pay dividends?
No, Zynex (ZYXI) stock does not pay dividends to its shareholders as of May 23, 2025.
When is the next Zynex dividend payment date?
Zynex (ZYXI) stock does not pay dividends to its shareholders.
What is the beta indicator for Zynex?
Zynex (ZYXI) has a beta rating of 1.1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.